Metabolic Syndrome

Adil O. Bahathiq had initial experience of the research tools with Professors Ian Cooke and William Ledger at University of Sheffield, U.K.He found newdata the Fallopian tube and epididymis for his Ph.D. Then he conducted a new line of research that helped and improved the healthof the community. He hasdeveloped this area after years of experience in research, evaluation, teaching and administration both in hospital and educational institutions. This research areawaschosen because of the lack of data relating to obesity and the metabolic syndrome in the children and adults of the Makkah community. The findings of this research have beenbeneficial to the authorities in the fields of education and health in Saudi Arabia.

Diabetes, Obesity, Reproductive Endocrinology, Metabolism

Dr Tsiani’s research focus is to investigate the biological effects and the mechanism of action of plant-derived polyphenols. She has expertise in muscle metabolism, insulin resistance, cell signaling pathways and cancer biology. Both in vitro cell culture models as well as in vivo, animal models are used in her research studies. Normal cellular function is maintained by a complex system of signaling molecules (signaling cascades) that coordinate cell response to various stimuli. Defects in cellular signaling can lead to diseases such as diabetes (insulin resistance) and cancer. Understanding cell signaling is of major importance and provides the basis for defining novel tools for targeting signaling molecules and pathways involved in diseases. Dr Tsiani’s research has indicate strong antidiabetic and anticancer properties of plant polyphenols

Diabetes, Metabolism, Insulin Resistance, Cell Signalling

1991-1993: Medical Doctor --- Balikesir Gonen Tutuncu cottage hospital, Turkey 1994-1998: Surgery Residency Program --- Istanbul Ministry of Health Taksim Training and Research Hospital, Surgery Department, Turkey 1998-2001: Specialist Doctor (General Surgeon) --- Bursa Cekirge Military Hospital, Surgery Department, Turkey 2002-2007: Specialist Doctor (General Surgeon) --- Buca Seyfi Demirsoy State Hospital, Izmir, Turkey 2007-2009: Specialist Doctor (General Surgeon) --- Izmir Bozyaka Training and Research Hospital, Surgery Department, Izmir, Turkey 2009-2011: Specialist Doctor (General Surgeon) --- Izmir, Tepecik Training and Research Hospital, Surgery Department, Izmir, Turkey 2011-Present: Specialist Doctor (General Surgeon) --- Buca Seyfi Demirsoy State Hospital, Izmir, Turkey

General Surgery, Gastroenterology, Hepatology, Pediatric Surgery

Ivanova L.A. was awarded the degree of Doctor of Sciences in February 2009. She was was awarded the academic title of professor of endocrinology in December 2009. She is the head of Endocrinology Department at Kuban State Medical University since 1995. She has published more than 123 articles and abstracts in Russian and international journals. She is a reviewer of SCIENCEDOMAIN.

Endocrinology, Polycystic ovary syndrome(PCOS), Metabolic Disorder,

Dr. Marrero received a B.A. (1974), M.A. (1978) and Ph.D. (1982) in Social Ecology from the University of California, Irvine. He joined the IU School of Medicine in 1984 and became the J.O. Ritchey Professor of Medicine in 2004. He was a member of the Diabetes Research & Training Center and served as Director of the Diabetes Prevention and Control Division. He is currently the Director of the Diabetes Translational Research Center. Dr. Marrero is an expert in the field of clinical trails in diabetes and translation research which moves scientific advances obtained in clinical trails into the public health sector. He helped design the Diabetes Prevention Program and the TRIAD study, which evaluated strategies to improve diabetes care delivery in managed care settings. His research interests include strategies for promoting diabetes prevention, care settings, improving diabetes care practices used by primary care providers, and the use of technology to facilitate care and education. Dr. Marrero was twice awarded the Allene Von Son Award for Diabetes Patient Education Tools by the American Association of Diabetes Educators, nominated to Who�s Who in Medicine and Health care in 2000, served as Associate Editor for Diabetes Care (1997-2002) and is currently the Associate Editor for Diabetes Forecast. He was selected as Alumni of the Year for University of California Irvine in 2006 and The Outstanding Educator in Diabetes in 2008 by the American Diabetes Association.

Diabetes, obesity, Translational Medicine, Endocrinology and Metabolism, Clinical Diabetes,

Dr. Shaodong Guo is Associate Professor in the Department of Nutrition and Food Science at Texas A&M University College. He received his Ph.D in Physiology from Peking University, China. Then he completed his postdoctoral research training in Genetics, Biochemistry, and Medicine in the Chinese Academy of Sciences, the University of Illinois at Chicago, and Harvard University, respectively. Dr. Guo was an Instructor in Medicine at Children's Hospital Boston and Harvard Medical School for two years prior to joining the faculty at Texas A&M Health Science Center. Currently, Dr. Guo serves as senior editor for the Journal of Endocrinology and Journal of Molecular Endocrinology, two major official journals of Endocrine Society of Europe, UK, and Australia, and he is the textbook chapter writer for Metabolic Syndrome edited by Rexford Ahima and published by Springer in 2016. Dr. Guo’s research has been funded by American Diabetes Association (ADA), American Heart Association, and the National Institute of Health. He is a recipient of ADA junior faculty award, career development award, and Richard R. Lee Award. His work has been published in a number of journals including the JBC, Endocrinology, Hypertension, Diabetes, Circulation Research, AJP, MCB, and Nature Medicine, receiving about 5,000 citations with an h-factor of 34 based on Google Scholar Citation.

Mechanisms of Insulin Resistance and Diabetes Mellitus Fatty Liver, Metabolic Syndrome and Disease, Diabetic Cardiomyopathy and Heart Failure Nutrient and Hormonal Signaling and Biology Nutritional and Therapeutic Intervention of Metabolic/Cardiac Diseases Hypertension.

Vivek Kamath founder and CEO of heal the world organization is a Reiki Master, Mexican Healer, Melchizedek Healer, Crystal Healer and Past Life Regression Therapy Expert. He has healed many diabetic patients (Type1, Type2, Type 3/1.5/LADA) without any medicines. He has also healed blood pressure (both high and low blood pressure), heart disease (removed the heart blockages), removed kidney stones, ovarian cysts, fibrosis of the breast, fatty liver, lungs disease, cured sinusitis, sever joint pain, lumbar L5 spinal disk pain, Sciatica pain, neck pain, constipation, rheumatoid arthritis, glaucoma, migraines, headaches, insomnia, stomach related problem, IBS, diabetic gum problems, skin problems( dry skin, eczema) and chronic nasal allergies, nasal blockages without any medicines. He is currently healing 5 Cancer Patients. Some are recovering from Cancer. Some of the above treatments have been completed within a week to maximum 1 month duration. Vivek Kamath received a Certificate of Recognition during 25th Global Diabetes Summit and Expo held in Dubai during December1st week in 2017 for his “Key Note Speech on Diabetes Cure”.

Diabetes, Cancer, Clinical Diagnosis, Endocrine Disorder, Metabolic Disorder

Dr Ntethelelo Sibiya is a young researcher at the University of KwaZulu-Natal, South Africa. Recently he has been focusing on the evaluation of novel transdermal approaches to manage diabetes mellitus, primarily interested on the markers of cardiovascular, renal and cognitive function using animal experimental models. He has also been involved in the screening of medicinal-derived compounds for anti-hyperglycaemic and immunodulatory properties, using cell line models. Additionally, he is also involved in teaching and supervision of post-graduate students in the university.

Diabetes Mellitus, Cardiovascular, Renal and Cognitive diseases, Endocrine Disorder and Metabolism

Penny is a nutrition biochemist and dietitian scientist, holding a Master of Science in Dietetics and Nutrition, with a specialization in nutrition biochemistry and is a licensed and Registered Dietitian. Her research interests include pre- and type 2 diabetes, cardiovascular disease, and obesity and what these conditions have in common so they can be treated synergistically and more efficiently at the individual and population level. Additionally, Penny is also interested in dietary components and interventions that work to prevent, improve, or worsen these conditions. Being that cultural and ethnic background play an influential role in disease prevention and management, she considers research in these contexts. Penny's specialty and passion lie in being the bridge between nutrition science and public health, receiving numerous community and industry awards and recognition for her initiatives and involvement in the communities she serves. Inspired by her diabetic past, having been diagnosed with prediabetes at the age of 12 years old and reversing it one year later, Penny is passionate about finding evidence-based and culturally-tailored dietary solutions in addressing the diabetes and chronic disease epidemic. Having varied clinical and community experience, she has been invited to speak in corporate and hospital sectors but also enjoys giving back through philanthropic community presentations to low-income and minority communities that are among those at highest risk and prevalence of diabetes, cardiovascular disease, and obesity. With a growing international community of over 10,500 followers, Penny also enjoys mobilizing social media such as Twitter (@pbroo003) as a means to provide evidence-based information and research to layperson communities who are interested in preventing or better managing these conditions. Recently, she has served as a consultant to the Florida International University (FIU) Marketing Department (part of the FIU School of Business) to create and develop the first nutrition curriculum component for their Health & Fitness Marketing Certificate program. And currently, Penny is engaged in an invited appointment at FIU where she is an independent consulting researcher working in cross-cultural dietary assessment research.

Diabetes, Dietetics and Nutrition,

Diana Alvarado has got her first Researcher Professor position in Universidad del Valle de México a year ago and became part of the Researchers National System. She has acquired experience on molecular biology and techniques to detect DNA damage, like Comet assay and Micronuclei assay, as well as the spectrophotometric techniques to detect oxidative stress. One of the reasons for which she chose as her research line obesity, is because Mexico is amongst the first world places of obesity and related diseases as obesity and metabolic syndrome. With this research line she has the purpose to show a practical, yet early way to diagnose, prevent and treat in a more specifical way, all of the comorbilities related to obesity, which have become at least in our country, the main causes for death. Passionated for her work, as a young researcher, she is looking for opportunities to establish collaboration networks with other researchers doing similar things which could be eventually translated into wellbeing for people with this disease.

Diabetes, Endocrinology, obesity and metabolic syndrome

Dr. Ghazeeri, an Associate Professor of Obstetrics and Gynecology, is a practicing Obstetrician/Gynecologist at American University of Beirut Medical Center since 2004. She received her medical degree from the American University of Beirut and completed residency in Obstetrics and Gynecology at AUB. She also completed a fellowship in Reproductive Endocrinology & Assisted Reproductive Technology at the University of Tennessee. In 2008 she received her Diploma in Clinical Embryology at University of Leeds. She is the director of residency program of Obstetrics and Gynecology at American University of Beirut Medical Center since 2008. Her research interests are in Preimplantation Genetic Diagnosis, fertility preservation, Polycystic Ovary Syndrome treatments , and In-vitro fertilization . Since the year 2000, she has published more than 48 scientific papers in peer reviewed. She has presented in several scientific meetings. She is a member in multiple scientific and medical societies such as the American College of Obstetrics and Gynecology, the American Society for Reproductive Medicine. She is also a Technical Consultant in the American Board of Bioanalysts.

Reproductive Endocrinology, Obstetrics and Gynecology, Metabolic Syndrome Diseases

Hidekatsu Yanai, MD, PhD, Fellow of American College of Physicians (FACP), is the Director of the Department of Internal Medicine and Clinical Research and Trial Center, National Center for Global Health and Medicine Kohnodai Hospital, Japan. He is also the Professor of Wayo Women’s University, Japan. He obtained his MD and PhD degrees in National Defense Medical College and Hokkaido University School of Medicine, respectively. He studied as Invited PhD Research Fellow in the National Institutes of Health (NIH), USA. He is the Editor-in-Chief of “Journal of Endocrinology and Metabolism” and also an Editorial Board Member of ten medical journals. He has 195 published English papers in refereed medical journals.

Metabolic Syndrome, Diabetes, Endocrinology and Metabolism, Obesity, insulin resistance,etc

Dr Gonzalez earned a PhD in Molecular Biology from University of Wales Swansea in 2007. An Associate Professor position within the Reproductive Biology and Gynaecological Oncology group, Swansea University, Dr Gonzalez’s research focuses on investigating the underlying causes of female infertility and gynaecological cancers. Dr Gonzalez's research interests also include the development of targeted therapies, drug repositioning, and development of molecular methods for disease diagnosis. Her aim is to translate research findings into clinical relevant observations for patient benefit. She has published numerous peer-reviewed articles and reviews, and acts as editorial member and reviewer for several journals

Her interested in female infertility included the study of Polycystic ovary syndrome (PCOS), a common reproductive endocrine disorder that affects 5-10% of premenopausal women. PCOS features include hyperandrogenism, chronic anovulation, infertility, impaired glucose tolerance, hyperinsulinaemia and insulin resistance, which increases the risk of diabetes mellitus and cardiovascular disease

Dr. Jun Sun is a tenured Associate Professor at the University of Illinois at Chicago (UIC) and a Professor in Jesse Brown VA Medical Center, Chicago, U.S.A.. She is a fellow of American Gastroenterological Associate. Her research interests are host-microbiome interactions in inflammation and cancer. Her key achievements include 1) characterization of vitamin D receptor regulation of gut microbiome in intestinal homeostasis and inflammation, 2) identification of bacteria in regulating intestinal stem cells, and 3) identification and characterization of the Salmonella effector protein AvrA in host-bacterial interactions. Dr. Sun has published over 120 scientific articles in peer-reviewed journals, including Cell Stem Cells, Nature Genetics, Gut, JBC, American Journal of Pathology, American Journal of Physiology-GI. She is in the editorial board of more than 10 peer-reviewed international scientific journals. She services study sections for the NIH, American Cancer Society, and other national and international research foundations. Her research is supported by the NIH, DOD, and a few other research awards.

Bacterial Regulation, Obesity, Colon Cancer, Inflammatory Bowel Diseases, Metabolic Syndrome

Prof. Jordi Salas Salvadó has completed his PhD in 1985 from Universitat de Barcelona. He is the director of Human Nutrition Unit Research and Professor of Nutrition and Bromatology at Universitat Rovira i Virgili and Head of the Clinical Nutrition Unit in Sant Joan University Hospital in Reus. He has published more than 389 papers in reputed journals (SCI), has been citated more than 9000 times and has a H Factor of 44. He has been the Principal Investigator in so many research projects and has directed 19 Doctoral Theses, all of them obtined the maximum calification.

human clinical trials, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiovascular disease.

Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. Dr. Ellahham is Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ). He is Certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). He is the recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015. He is one the nominees for Safe Care magazine Person of the Year in the United States.

Cardiology, Cardiac Surgery, Cardiac Diseases

Narayan Hosmane Completed his B.S. and M.S from Karnatak University, Dharwar, India Organic, Inorganic and Physical Chemistry. He Completed his Ph.D. in 1974 from University of Edinburgh, Edinburgh, Scotland Organometallic/Inorganic Chemistry. From August 1998 - June 2001 he served as a Full Time Professor at Northern Illinois University, USA. Now, at present he is Distinguished Research Professor and Inaugural Board of Trustees Professor at Northern Illinois University, USA.

Chemistry, Metabolism, Biochemistry

Dr. Mahir Jallo, Clinical Professor of Medicine & Senior Consultant, Internal Medicine - Diabetes & Endocrinology in Gulf Medical University – UAE & Faculty in the Canadian Academy of Natural Health. Granted his MB,ChB from Mosul Medical College in IRAQ, his postgraduate Board Certification in Internal Medicine CABM from the Arab Board, his Fellowship of American College of Endocrinology FACE & certified with Diploma in Dyslipidemia from Boston University School of Medicine from USA. He joined the JCI Accredited Gulf Medical college Hospital & Research Center in U.A.E in 2004 establishing the Diabetes & Endocrinology care in the hospital & the Endocrinology Module coordinator for MBBS Program.

Internal Medicine, Diabetes & Endocrinology

Dr Simona Di Francesco, Director Department of Urological, Biomedical and Translational Sciences, completed her PhD in Clinical and Experimental Medicine and Surgery (CEMS), School of Advanced Studies , Department of Medicine and Aging during 2011-2014. At Present she is Director and Founder of Department of Urological, Biomedical and Translational Sciences People’s University Nicholas Copernicus, Cassino (RM), Italy as well as she is a Professor of Urology School, Department of Biomedical, Oral Sciences and Biotechnologies in G.D’Annunzio University of Chieti-Pescara ,Italy

Metabolic Syndrome, cardiovascular disease, Internal Medicine, Metabolic disorders, vascular damage

A passionate health and wellness educator, with extensive 17 years immersion in promoting public health education, particularly on Type 2 Diabetes and Obesity awareness. A seasoned educator, who has mastered the effective conduct of cooking and physical fitness classes across various groups and audiences. Accustomed to conceptualizing effective and comprehensive wellness programs that are consumer and environment-friendly, safe, and sustainable . Naturally competent at inspiring and motivating people towards good nutrition, proper eating habits , as well as lifestyle change. A nutritionist , an entrepreneur and a tireless volunteer with unperturbed zealousness for healthy lifestyle.

Fitness, Type 2 Diabetes, Obesity

Dr. Vincenzo Costigliola has more than 40 years of medical practice after graduating in Medicine at the University of Naples (Italy), and a post-degree specialization in Anesthesiology and Intensive Care from the Università di Pisa (Italy). He is a Founder & President of European Medical Association (Belgium). He has also co-founded the European Association for Preventive, Predictive and Personalized Medicine, and is current President (Belgium). He was formerly the Chief of Medical Services in the Italian Navy. Over the years, Dr Costigliola has widened his specializations into Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drug Abuse, Emergency Treatment, and Disaster Action.He is the Medical Advisor to OTAN and W.E.U. Bruxelles. He is a member of the International Advisory Board of the King Abdulaziz University, Jeddah (Saudi Arabia); a Board member of the European Biotechnology Thematic Network Association (Italy); and a member of the Editorial Advisory Board of the Journal of Psychiatry in Primary Care. He is a renowned speaker at numerous International Conferences and Congresses. He is multilingual and is proficient in 5 languages; English, Italian, French, Spanish and Portugese.

Medicine, Clinical Trials, Internal Medicine,Emergency Medicine,Family Medicine,Holistic Medicine,Diabetes

Dr. Arturo Solís Herrera, MD, PhD., has been Graduated from Institute Polytechnic Nacional, from CDMX, in 1978 as Medicine Doctor, with the specialties including Ophthalmology, in the National University of Mexico, and Neuro-Ophthalmology, at INNN, México. Later on he obtained his Master Science Degree from University of Aguascalientes, México, and thereafter a PhD in Pharmacology, Universidad de Guadalajara, México. Dr. Solís Herrera is director and founder of Human Photosynthesis® Research Center, in Ags., México, in 2007; where he has continued his research until today.

Human Photosynthesis, Metabolism

Dominico Merante joined DSD in March 2007 as Senior Director of Clinical Development at the newly opened R&D office in Gerrards Cross, United Kingdom. In July 2010 became European Head of Frontier/Opportunity and Metabolism. In 2011-2012 successfully led, as global clinical lead, the US phase 2 adaptive study of mirogabalin in painful diabetic neuropathy. Study results were published in Diabetes Care in December 2014. 3 years + 3 months of clinical management/leadership training experience in the Italian Navy working at the Infirmary of the Naval Academy as Lieutenant Medical Officer and on Nave Ammiraglio Magnaghi as Chief Medical Officer.

diabetes, endocrinology, cardiovascular, dyslipidemias, hypertension, neuroscie

Arie Franx holds an MD-degree of the Free University in Amsterdam and a PhD-degree of the University of Utrecht. He specialized in obstetrics/ gynaecology and attended leadership programs at INSEAD (Fontainebleau, France) and at Harvard Business School and Harvard School of Public Health (Boston, MA, USA). He is currently Professor of Obstetrics, Chair of the Division Woman and Baby en Director of the Ob/Gyn Specialty Training in the University Medical Centre Utrecht. His research interest include pregnancy complications, cardiovascular health in women, and organization and quality of care. He has published over 150 papers in international peer-reviewed scientific journals .

pregnancy complications, cardiovascular health in women, and organization and quality of care

Dr El Habachi is a Professor in the Department of Physiology and the Academic Director of the Alexandria Clinical Research Centre in the Faculty of Medicine, Alexandria University, Egypt. She is a multilingual Professor with a track record of establishing multinational partnerships, and teaches in both English and French. She has been pivotal in establishing the University Clinical Research Centre. Part of her pre-doctoral training was conducted in the Heart Science Centre, Imperial College, UK. In May 2006 she studied clinical research and GCP, University of Maryland USA. She has a broad research experience in national and international projects.

Nutrition,Stress Management,ClinicalTrials,Clinical Reseach

Dr. Kang Choon Lee is Haengdan Distinguished Professor at the SungKyunKwan University (SKKU), Korea, and was director of the Center of Excellence for Future Pharmaceutical Education and Research in the College of Pharmacy at SKKU. He served as a professor and dean at the College of Pharmacy as well as the director of the Institute of Pharmaceutical Science. Prior to joining SKKU in 1992, Dr. Lee was a principal scientist at Dong-A Pharmaceutical Co. for ten years before joining Chonnam National University as a professor of pharmacy. For over 30 years, Dr. Lee’s Drug Targeting Laboratory has been focused on immuno-targeting including immunotoxins, preformulation and bioconjugation of peptide and protein drugs. Dr. Lee is internationally recognized as one of the leading experts in site-specific peptide/protein PEGylation and firstly demonstrated the therapeutic potential of novel site-specific PEGylated drugs such as GLP-1 and TRAIL. He has published over 150 papers in peer-reviewed journals and served as an invited speaker at many international conferences. Dr. Lee is an inventor on more than 20 patents related to specific bioconjugation and modification of peptide/protein drugs. He served as president of the Korean-American Pharmaceutical Scientists Association and vice-president of the Pharmaceutical Society of Korea and Korean Society of Pharmaceutical Science and Technology. Dr. Lee is a recipient of the Distinguished Pharmaceutical Scientist Award from the Pharmaceutical Society of Korea in 2002 and honored as a Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2003. He currently serves on the editorial advisory board of many international scientific journals including Pharmaceutical Research, Pharmaceutical Development and Technology, PharmSciTech and Journal of Drug Delivery. In 2012, he founded B&L DeliPharm Inc. Korea, a pharmaceutical company focused on clinically translating and commercializing site-specific engineered peptide/protein drugs developed by his laboratory and also he co-founded and serves as a Board Member of Theraly Pharmaceuticals, USA.

Metabolism,Clinical Research, Endocrinology